Literature DB >> 28129986

Pancreatic cancer: are more chemotherapy and surgery needed?

Gaël Deplanque1, Nicolas Demartines2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28129986     DOI： 10.1016/S0140-6736(17)30126-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

1.  Synthesis and assessment of ZD2-(68Ga-NOTA) specific to extradomain B fibronectin in tumor microenvironment for PET imaging of pancreatic cancer.

Authors:  Songqi Gao; Jingcan Qin; Olga Sergeeva; Maxim Sergeev; Peter Qiao; Sarah Roelle; Norbert Avril; Zhenghong Lee; Yajuan Li; Zhengrong Lu
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-10-15

2.  Late Pancreatic Anastomosis Stricture Following Pancreaticoduodenectomy: a Systematic Review.

Authors:  Alban Zarzavadjian Le Bian; Manuela Cesaretti; Nicolas Tabchouri; Philippe Wind; David Fuks
Journal:  J Gastrointest Surg       Date:  2018-07-06       Impact factor: 3.452

3.  Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Takashi Suzuki; Shozo Mori; Takayuki Shimizu; Kazuma Tago; Nobuhiro Harada; Kyung-Hwa Park; Yuhki Sakuraoka; Takayuki Shiraki; Yukihiro Iso; Taku Aoki; Keiichi Kubota
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

4.  Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics.

Authors:  Xinlu Liu; Yejing Weng; Peng Liu; Zhigang Sui; Lei Zhou; Yinpeng Huang; Lihua Zhang; Yukui Zhang; Xiaodong Tan
Journal:  Onco Targets Ther       Date:  2018-06-06       Impact factor: 4.147

5.  WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer.

Authors:  Shaobin Huang; Chensong Huang; Wei Chen; Yifeng Liu; Xiaoyu Yin; Jiaming Lai; Lijian Liang; Qian Wang; Anxun Wang; Chaoxu Zheng
Journal:  Int J Oncol       Date:  2018-05-25       Impact factor: 5.650

6.  Instantaneous mutation rate in cancer initiation and progression.

Authors:  Shuhao Sun; Fima Klebaner; Xinan Zhang; Tianhai Tian
Journal:  BMC Syst Biol       Date:  2018-11-22

Review 7.  Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma.

Authors:  Yun Zhang; Zi-Xing Huang; Bin Song
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

8.  Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.

Authors:  Xu-Jie Liu; Liang Li; Xiu-Jun Liu; Yi Li; Chun-Yan Zhao; Rui-Qi Wang; Yong-Su Zhen
Journal:  Int J Nanomedicine       Date:  2017-07-24

9.  Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer.

Authors:  Xiaoyu Liu; Changyu Li; Junhao Li; Tianzhu Yu; Guofeng Zhou; Jiemin Cheng; Guoping Li; Yang Zhou; Wenhui Lou; Xiaolin Wang; Gaoquan Gong; Lingxiao Liu; Yi Chen
Journal:  J Cancer       Date:  2018-05-22       Impact factor: 4.207

10.  Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway.

Authors:  Chao Yu; Shiyu Chen; Yuntao Guo; Chengyi Sun
Journal:  Theranostics       Date:  2018-05-11       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.